Now Available:
Download the podcast of Dr. Cohen's video presentation

CME Opportunity:

International Society of Extremity MRI in Rheumatology Conference:
Chicago, April 10, 2008

With biweekly and special edition newsletters, Musculoskeletal Report is the top online resource for staying abreast of the most current and clinically relevant information in the field of musculoskeletal disease and treatment. MSK Report provides cutting-edge scientific updates through in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts.

Consumer News: Learn what your patients are reading in the popular press

Gender Bias at Play in Treatment of Knee Osteoarthritis
Men are more likely than women to be recommended for total knee replacement surgery...

New from PubMed: Keep up-to-date with what is on PubMed

Will Hematopoietic Stem Cell Transplantation Cure Human Autoimmune Diseases?
Researchers analyzed hematopoietic stem cell transplantation as an acceptable therapy for autoimmune diseases...

MSK Video Report:
New Treatment Developments
Dr. Marc Cohen presents new drugs and treatment options for RA in the final installment of our 4-part series, "RA and Infusion Therapy"...

AAOS 2008: AAOS Researchers Warn of Alendronate Fracture Risk
Two studies reported at the AAOS meeting warned of a possible increase in risk of low-energy or stress fractures associated with long-term use of alendronate...

AAOS 2008: AAOS Debates Gender-Specific Joint Implants
Joint replacement experts say implant should fit body, not gender...

AAOS 2008: AAOS Panel Presents Hip Resurfacing as Option for Some Younger Patients
Hip resurfacing may emerge as a preferred option for some younger arthritis patients...

Autoimmunity: Avoidable Hospitalizations Common Among Older, Poorer SLE Patients
Rheumatologists have a key role in preventing avoidable hospitalizations among older, poorer patients with systemic lupus erythematosus (SLE)...

BioPharm Business: Lilly's Forsteo Receives Positive Opinion From European Committee for Medicinal Products for Human Use to Treat Glucocorticoid-Induced Osteoporosis
Eli Lilly and Co announced that they have received a positive opinion recommending approval of Forsteo (teriparatide [rDNA origin] injection) for the treatment of glucocorticoid-induced osteoporosis (GIOP) in adults at increased risk for fracture...

To remove your e-mail address from our mailing list, please reply to this e-mail with "unsubscribe" in the subject line. For questions and comments regarding this newsletter please contact info@mskreport.com.